Cresco Labs Inc. (CRLBF) EBT Margin (2020 - 2026)

Cresco Labs (CRLBF) has reported EBT Margin for 7 consecutive years, with 2.07% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT Margin fell 375.0% year-over-year to 2.07%; the trailing twelve-month figure through Jun 2026 stood at 18.02% (down 1552.0% YoY), and the FY2025 full-year result was 21.35%, down 1300.0% from the prior year.
• EBT Margin eased to 2.07% in Q2 2026 per CRLBF's latest filing, from 1.85% in the prior quarter.
• Across five years, EBT Margin topped out at 6.81% in Q4 2023 and bottomed at 78.6% in Q4 2022.
• Historically, EBT Margin has averaged 16.4% across 5 years, with a median of 6.74% in 2025.
• The widest YoY moves for EBT Margin: up 12072 bps in 2022, down 7313 bps in 2022.
• Over 5 years, EBT Margin stood at 78.6% in 2022, then surged by 109 bps to 6.81% in 2023, then sank by 74 bps to 1.74% in 2024, then sank by 3270 bps to 55.06% in 2025, then soared by 96 bps to 2.07% in 2026.
• According to Business Quant data, EBT Margin over the past three periods registered 2.07%, 1.85%, and 55.06% for Q2 2026, Q1 2026, and Q4 2025 respectively.